Bruce C. Stouch
Corporate Officer/Principal at Philadelphia College of Osteopathic Medicine
Profile
Bruce C.
Stouch is currently the Director of Biostatistics & Clinical Epidemiology at Philadelphia College of Osteopathic Medicine, Director of Biometrics Coordinating Center at National Institute of Child Health & Human Development, and Vice President of Biometrics at Arcion Therapeutics LLC.
He previously worked as the Director of Scientific Data Management at Johnson & Johnson.
Stouch received his undergraduate degree from Lafayette College and his doctorate from Temple University (Pennsylvania).
Bruce C. Stouch active positions
Companies | Position | Start |
---|---|---|
Philadelphia College of Osteopathic Medicine | Corporate Officer/Principal | - |
National Institute of Child Health & Human Development | Corporate Officer/Principal | - |
Former positions of Bruce C. Stouch
Companies | Position | End |
---|---|---|
JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Arcion Therapeutics LLC
Arcion Therapeutics LLC Pharmaceuticals: MajorHealth Technology Arcion Therapeutics LLC develops topical therapies for chronic pain. The firm offers innovative topical treatments to provide pain relief with convenient application and reduced systemic side effects. Its product pipeline comprises multiple candidates to treat neuropathic pain, a complex and debilitating form of chronic pain. The company is headquartered in Baltimore, MD. | Corporate Officer/Principal | - |
Training of Bruce C. Stouch
Lafayette College | Undergraduate Degree |
Temple University (Pennsylvania) | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
JOHNSON & JOHNSON | Health Technology |
Private companies | 2 |
---|---|
Arcion Therapeutics LLC
Arcion Therapeutics LLC Pharmaceuticals: MajorHealth Technology Arcion Therapeutics LLC develops topical therapies for chronic pain. The firm offers innovative topical treatments to provide pain relief with convenient application and reduced systemic side effects. Its product pipeline comprises multiple candidates to treat neuropathic pain, a complex and debilitating form of chronic pain. The company is headquartered in Baltimore, MD. | Health Technology |
National Institute of Child Health & Human Development | Government |
- Stock Market
- Insiders
- Bruce C. Stouch